Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from 18 F fluorodeoxyglucose PET/CT images in gastric cancer.
Frontiers in immunology（2022）
Abstract
This PET/CT radiomics model provided a promising way to assess the tumor immune microenvironment and to predict clinical outcomes and chemotherapy response. The RTIMS signature could be useful in estimating tumor immune microenvironment and predicting survival and chemotherapy benefit for patients with gastric cancer, when validated by further prospective randomized trials.
MoreTranslated text
Key words
Gastric cancer,Positron Emission Tomography-Computed Tomography (PET/CT),chemotherapy,predictive,radiomics,tumor immune microenvironment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined